Alexis Beatty is a Cardiology physician affiliated with University of California, San Francisco. OpenAlex indexes 127 publications with 6,671 citations (h-index 35); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
535 Mission Bay Blvd S
San Francisco, CA 941432156
Telephone
415-353-2873Provider last certified this registry record 18 Jan 2022.
Clinical trials
- The Heart Health After Cardiac Treatment Study
Sponsor: University of California, San Francisco
- Heart Health After Cancer Treatment (HEART-ACT)
Sponsor: University of California, San Francisco
- MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85%Statin21.5%Atorvastatin Calcium67%Rosuvastatin Calcium33%Part D≥33 patientsBeta blocker16.8%Metoprolol Succinate82%Carvedilol19%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
7.6%SGLT2 inhibitor5.7%Jardiance100%Part D≥12 patientsGLP-1 receptor agonist1.9%Wegovy100%Part D<11 patientsBlood & clotting
7.4%Factor Xa inhibitor4.4%Eliquis100%Part D<11 patientsP2Y12 inhibitor3%Clopidogrel52%Brilinta48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2011–2012 per NIH RePORTER. The latest:
- High sensitivity Troponin T as a novel predictor of cardiovascular events
University of California, San Francisco
FY2012$61,542F32HL110518 - High sensitivity Troponin T as a novel predictor of cardiovascular events
University of California, San Francisco
FY2011$63,182F32HL110518
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Understanding activity and physiology at scale: The Apple Heart & Movement Study
npj Digital Medicine
2024 - Factors Associated With Long COVID Symptoms in an Online Cohort Study
Open Forum Infectious Diseases
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”